Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Porton Partners with BioMap for AI Based Gene Therapy Development

publication date: Nov 8, 2023

Suzhou Porton Advanced will partner with BioMap, an AI company that has developed the Xtrimo platform that offers Large Language Models to predict the behavior of proteins. The collaboration will use Porton Advanced's novel Adeno-Associated Virus (AAV) vector technology platform and relevant research data to develop AAV assembly efficiency models and an assembly distribution model. The two companies plan to build large-scale life science models that speed up the integration of experimental platforms and intelligent big data analysis platforms. BioMap is headquartered in Menlo Park, CA with operations in Singapore, Beijing and Suzhou. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital